Clinical Trials Logo

Lichen Planus clinical trials

View clinical trials related to Lichen Planus.

Filter by:

NCT ID: NCT05730855 Completed - Oral Lichen Planus Clinical Trials

Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions

Start date: November 1, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate salivary expression of lncRNA DQ786243 as a potential marker for diagnosis of oral potentially malignant lesions compared to normal controls and its effect on salivary expression of miRNA146a.

NCT ID: NCT05699499 Completed - Clinical trials for Lichen Planus of Nail

Analysis of Impact of KeryFlex on Quality of Life for Retronychia or Lichen Planus Adult Patients

Start date: April 11, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the overall effect of KeryFlex study intervention on quality of life and functionality for patients with retronychia or nail lichen planus.

NCT ID: NCT05593432 Completed - Clinical trials for Cutaneous Lichen Planus

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Start date: November 23, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study will be to evaluate efficacy and safety of Ruxolitinib cream in participants With Cutaneous Lichen Planus. This is randomized, double-blind, vehicle-controlled (DBVC) study with a DBVC period of 16 weeks followed by an open label period (OLE) period of 16 weeks.

NCT ID: NCT05400057 Completed - Oral Cancer Clinical Trials

the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients

Start date: January 15, 2023
Phase:
Study type: Observational

Assessment The oncogenic potential of salivary microRNA-93 and microRNA-412-3p in oral lichen planus

NCT ID: NCT05396261 Completed - Vaginitis Clinical Trials

a Flexible Wound Dressing for the Management of Genital Skin Conditions

Start date: January 31, 2018
Phase: N/A
Study type: Interventional

The objective of the study is to determine the efficacy of 7-0940 in the management of genital skin conditions in female patients

NCT ID: NCT05188521 Completed - Clinical trials for Cutaneous Lichen Planus

Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus

Start date: January 11, 2022
Phase: Phase 2
Study type: Interventional

This research study is evaluating the safety and efficacy of Baricitinib in treating Cutaneous Lichen Planus (LP).

NCT ID: NCT05139667 Completed - Oral Lichen Planus Clinical Trials

Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus

Start date: May 20, 2019
Phase: Phase 4
Study type: Interventional

tacrolimus has been widely used as an immunosuppressant. the objective of this study was to evaluate the clinical efficacy of tacrolimus 0.1 % in muco adhesive patch compared to tacrolimus or corticosteroids in paste forms for symptomatic oral lichen planus, and to investigate the effect of topical tacrolimus or corticosteroids on the expression of caspase-3 in oral lichen planus as an early marker of apoptosis using immunohistochemically analysis

NCT ID: NCT05127083 Completed - Oral Lichen Planus Clinical Trials

Oral Lichen Planus Treatment

Start date: June 4, 2018
Phase: N/A
Study type: Interventional

Oral lichen planus (OLP) is a chronic inflammatory and immune-mediated disease affecting the oral mucosa. OLP presents with asymptomatic, lacelike white stripes and/or symptomatic red, ulcerated mucous membranes. Eating, drinking and oral hygiene procedures may be painful resulting in reduced quality of life (QOL). Photodynamic therapy (PDT) is a new suggestion for OLP treatment PDT is a successful treatment mo- dality for premalignant and malignant diseases of head and neck,gastrointestinal tract, lung, and skin In this study, the effect of photodynamic therapy with topical corticosteroid in oral lichen planus patients was compared

NCT ID: NCT05030415 Completed - Lichen Planus Clinical Trials

Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

Start date: August 12, 2021
Phase: Early Phase 1
Study type: Interventional

To evaluate the safety and efficacy of ixekizumab in lichen planus and lichen planopilaris clinical response by Total Body Surface (TBS) determination, Investigator Global Assessment (IGA) Score, Lichen Planopilaris Activity Index (LPPAI), and Frontal Fibrosing Alopecia Severity Score (FFASS).

NCT ID: NCT04991012 Completed - Oral Lichen Planus Clinical Trials

Evaluation of the Effectiveness of Photodynamic Therapy in the Treatment of Lesions of the Lichen Planus Type in the Oral Mucosa and Its Diagnostics With the Use of Autofluorescence, in Various Wavelength Ranges, in Combination With the Use of Texture Analysis and Fractal Dimension

Start date: February 8, 2020
Phase: Phase 2
Study type: Interventional

Lesions of the lichen planus type within the oral mucosa are now considered a potentially cancerous condition. One of the minimally invasive methods of treating these lesions is photodynamic therapy, and the gold standard in therapy is topical steroid administration